Upexi Inc
UPXI4.910USD
+0.140+2.94%
Handelsschluss 10/24, 16:00（ET）Kurse um 15 Minuten verzögert
187.91MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Upexi Inc Unternehmen
Upexi, Inc. is a brand owner specialized in the development, manufacturing and distribution of consumer products. The Company focuses on direct-to-consumer and Amazon brands. The Company’s brands include LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, Gumi Labs, and Upexi Distribution. LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements. Gumi Labs manufactures gummies and other products supporting its health and wellness products, including those products manufactured with hemp ingredients. Upexi Distribution manages the warehousing and logistic needs of the Company and provides storage, consolidation, assembly, Amazon preparation, distribution and fulfilment services to its brands and its manufacturing operation.
Upexi Inc Informationen
BörsenkürzelUPXI
Name des UnternehmensUpexi Inc
IPO-datumJun 24, 2021
CEO- -
Anzahl der mitarbeiter64
WertpapierartOrdinary Share
GeschäftsjahresendeJun 24
Addresse3030 Rocky Point Drive
StadtTAMPA
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl33607
Telefon17013535425
Websitehttps://upexi.com/
BörsenkürzelUPXI
IPO-datumJun 24, 2021
CEO- -
Führungskräfte von Upexi Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
585.37K
+60.32%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
349.14K
+252.17%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
585.37K
+60.32%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
349.14K
+252.17%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q1
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%
Nach RegionUSD
Name
Umsatz
Anteil
United States of America
14.57M
98.25%
Other
259.57K
1.75%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%
Aktionärsstatistik
Aktualisiert: Sat, Oct 18
Aktualisiert: Sat, Oct 18
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
MMCAP Asset Management
21.98%
Samara Special Opportunities
7.69%
GSR Growth Investments LP
3.92%
Marshall (Allan)
2.57%
Pantera Capital Partners LP
2.26%
Andere
61.59%
Aktionäre
Aktionäre
Anteil
MMCAP Asset Management
21.98%
Samara Special Opportunities
7.69%
GSR Growth Investments LP
3.92%
Marshall (Allan)
2.57%
Pantera Capital Partners LP
2.26%
Andere
61.59%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
23.83%
Corporation
11.61%
Individual Investor
5.95%
Investment Advisor
5.51%
Investment Advisor/Hedge Fund
1.00%
Research Firm
0.26%
Bank and Trust
0.24%
Venture Capital
0.14%
Andere
51.45%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
53
23.37M
39.68%
+23.17M
2025Q2
46
10.18M
21.50%
+7.63M
2025Q1
42
311.78K
28.56%
-35.31K
2024Q4
42
307.62K
23.29%
-32.82K
2024Q3
40
303.51K
29.16%
-55.91K
2024Q2
40
319.39K
30.68%
-45.58K
2024Q1
42
328.34K
32.32%
-46.59K
2023Q4
42
319.26K
31.43%
-34.26K
2023Q3
40
369.15K
37.28%
-46.01K
2023Q2
44
368.80K
38.85%
-28.58K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
MMCAP Asset Management
12.94M
21.98%
+12.94M
--
Jul 16, 2025
Samara Special Opportunities
4.53M
7.69%
+4.53M
--
Aug 29, 2025
GSR Growth Investments LP
2.31M
3.92%
-1.00
-0.00%
Jun 30, 2025
Marshall (Allan)
1.51M
2.57%
+1.36M
+899.43%
Jul 16, 2025
Pantera Capital Partners LP
1.33M
2.26%
+1.33M
--
Jun 30, 2025
Rudick (Brian Benjamin)
838.60K
1.42%
+400.00K
+91.20%
Jul 16, 2025
Salkind (Gene)
585.37K
0.99%
+220.24K
+60.32%
Jul 16, 2025
NewGen Asset Management Limited
577.19K
0.98%
+577.19K
--
Jun 30, 2025
The Vanguard Group, Inc.
500.84K
0.85%
+500.84K
--
Jun 30, 2025
Kathmere Capital Management
2.19M
3.72%
+2.19M
--
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Mon, Oct 6
Aktualisiert: Mon, Oct 6
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Datum
Art
Verhältnis
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
